The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
September 19th 2024
EDG-7500 was well-tolerated in healthy patients in Phase 1 while achieving gradient relief without LVEF reductions in the Phase 2 CIRRUS-HCM trial.
September 12th 2024
September 10th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Cardiology Case Report: Missed Dialysis
January 11th 2023In this case report, a man in his 50s with a history of ESRD, alcoholic cirrhosis, and anemia presents to the emergency department for evaluation of generalized weakness after missing his last 2 dialysis appointments. Check out the ECG and determine the most likely cause of the rhythm!
Heart Failure Risk Stratification Benefited Clinical Decision Making in Emergency Department
January 7th 2023The COACH trial reported a hospital-based strategy led to lower risk of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care in patients with acute heart failure.
More Than 1-in-4 Cardiologists Report Mental Health Conditions, Survey Finds
January 6th 2023Data from a 2019 survey of more than 5000 cardiologists across the globe suggests 28% of the field may be experiencing some form of mental health condition, with results also shedding light on predictors of mental health conditions.
SGLT2 Inhibitors Can Reduce Cardiometabolic Risk in People with Diabetes Using Metformin
January 6th 2023Using data from more than 55,000 people with diabetes using metformin is providing new insight into the apparent reductions in risk of negative cardiovascular and renal outcomes as well as all-cause mortality with use of SGLT2 inhibitors.
EVOLUTION HF Provides Overview of Global Trends in GDMT Use for Heart Failure
January 5th 2023Using real-world data from the US, Japan, and Sweden provides insight into contemporary trends in GDMT use, including initiation, uptitration, and discontinuation, following hospitalization among patients with heart failure with reduced ejection fraction.
Commotio Cordis: What to Know and How to Communicate with Patients, with Jesse Morse, MD
January 3rd 2023Jesse Morse, MD, a sports medicine specialist, discusses commotio cordis and how to effectively communicate with athletes and parents of young athletes about the diagnosis in the wake of an incident where a player collapsed during a recent NFL game.
Top Episodes of Don't Miss a Beat in 2022
December 28th 2022With less than a week to go until the close of 2022, our editorial team is celebrating the final week of the year by recapping some of our most popular stories and content from the past year. Here, we are highlighting our most popular episodes of the Don’t Miss a Beat Podcast from 2022.
Noncardiac Biomarker Could Aid in Predicting Myocarditis, Mortality in Some Cancer Patients
December 22nd 2022An observational study of data from patients with cancer treated with immune checkpoint inhibitors provides an overview of prognostic utility of noncardiac biomarkers for predicting myocarditis and all-cause mortality.
Leading Cardiology Organizations Call for Reinvention of Clinical Trials
December 19th 2022On December 16, the world's foremost cardiology organizations released a joint opinion statement calling for a reinvention of clinical trials to better suit the needs of the healthcare system in the 21st century.
Negative Perceptions of Cardiology Could Be Steering Internal Medicine Residents Away from Field
December 18th 2022Negative perceptions of cardiology and a shift in preferences among internal medicine residents could be driving potential fellows away from careers in cardiology, according to a new study.